Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Countries with the Highest Heart Disease Deaths Per Capita

In this article, we will be taking a look at the 5 countries with the highest heart disease deaths per capita. If you wish to learn about more, head straight to the 20 Countries with the Highest Heart Disease Deaths Per Capita.

5. Oman 

Death Rate per Capita: 0.003 

Oman faces a significant burden of heart failure (HF), particularly among older adults, with ischemic heart disease being the leading cause. The prevalence of HF in Oman is 5.17 per one thousand, with higher rates among males and increasing with age. Mortality rates for HF patients stand at 25% after one year, with higher rates at 1-month and 12-month follow-ups. Individuals aged 55 and above are commonly diagnosed with HF, with a higher incidence among men. treatment expenses for HF management in Oman can be substantial, encompassing medications, hospitalizations, and potentially surgical interventions, with costs varying based on factors like severity, treatment type, and access to healthcare services.

4. Ukraine 

Death Rate per Capita: 0.003 

Ukraine faces significant challenges in managing cardiovascular health, evident from its high cardiovascular disease (CVD) mortality rate, reaching 772.1 deaths per 100,000 for men and 440.9 deaths per 100,000 for women. Over 40% of the population has elevated total blood cholesterol levels, and nearly a quarter are obese. Additionally, obesity prevalence among children and teenagers is notable at 17.2%. Ukraine has 45 percutaneous coronary intervention (PCI) centers primarily performing acute interventions, alongside structured cardiac rehabilitation programs available in hospitals, health centers, and sanatoriums for severe cardiovascular disease patients.

3. Uzbekistan 

Death Rate per Capita: 0.0035 

Uzbekistan stands third among the countries with the highest heart disease deaths per capita, primarily ischemic heart disease, leading to high mortality rates. In 2019, the country recorded an age-standardized cardiovascular disease (CVD) mortality rate of 946 per 100,000 and an age-standardized CVD incidence rate of 1,493 per 100,000. CVD is the leading cause of death in Central Asia’s low- and middle-income countries, contributing to over 43% of disability cases and 9.0% of temporary disability cases. This growing burden of CVD and other non-communicable diseases presents a significant public health challenge for the region.

2. Azerbaijan 

Death Rate per Capita: 0.0038 

Azerbaijan stands among the top countries with the highest heart disease deaths, evident from its high mortality and incidence rates in 2019. With 42,138 deaths recorded due to CVD, the country faced an age-standardized mortality rate of 688 per 100,000 and an incidence rate of 1,224 per 100,000 population. Notably, raised blood pressure affected 25.8% of men and 23.0% of women. Men showed slightly higher prevalence rates of raised blood pressure and tobacco smoking compared to women. Despite this burden, the probability of premature mortality from CVD between ages 30 and 70 remained relatively low at 0.7%. Additionally, there are approximately 10.2 cardiologists per 100,000 inhabitants in Azerbaijan.

1. Tajikistan 

Death Rate per Capita: 0.0038 

Tajikistan stands first among the countries with the highest heart disease deaths per capita, particularly coronary heart disease, with 14,359 deaths attributed to it, accounting for 30.98% of total deaths. The country ranks number one globally for age-adjusted death rates due to cardiovascular diseases, with a rate of 389.75 per 100,000 population. Financial statistics show a GDP per capita of US$871 in 2019, with health expenditure accounting for 7% of GDP. Men exhibit higher rates of tobacco and alcohol use, while women show lower levels of physical activity. 

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also take a peek at the 20 Most Active States in the US and the 15 Highest Paying Countries for Biomedical Engineers. 

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.